Table 4 Survival under treatment
From: Osteopontin splice variants are differential predictors of breast cancer treatment responses
| Â | Years of survival | ||
|---|---|---|---|
Treatment | Mean | std | n |
hormone no (all subgroups) | 6.48 | 3.96 | 54 |
hormone yes (all subgroups) | 7.44 | 4.35 | 64 |
hormone alone | 9.89 | 2.00 | 18 |
hormone and chemo | 6.63 | 4.38 | 16 |
hormone and radiation | 5.10 | 4.63 | 10 |
hormone, chemo, radiation | 7.10 | 4.84 | 21 |
chemo no (all subgroups) | 8.30 | 3.79 | 30 |
chemo yes (all subgroups) | 6.57 | 4.22 | 89 |
chemo alone | 7.92 | 4.57 | 13 |
chemo and hormone | 6.63 | 4.38 | 16 |
chemo and radiation | 5.82 | 3.66 | 39 |
chemo, hormone, radiation | 7.10 | 4.84 | 21 |
chemo (CMF 6 courses every 28 days) | 6.27 | 4.36 | 55 |
chemo (AC 4 courses every 21 days, CMF 6 courses every 28 days) | 7.06 | 4.00 | 34 |
radiation no (all subgroups) | 8.23 | 3.90 | 47 |
radiation yes (all subgroups) | 6.21 | 4.17 | 72 |
radiotherapy alone | 10.00 | 1.41 | 2 |
radiation and hormone | 5.10 | 4.63 | 10 |
radiation and chemo | 5.82 | 3.66 | 39 |
radiation, chemo, hormone | 7.10 | 4.84 | 21 |